Altered mRNA processing and FVIII biosynthesis/function as determinants of phenotype variability in the frequent Arg2016Trp Haemophilia A patients.
Donadon, I.; Pinotti, M.     details >>

Anno: 2014

Development of a RNA-based therapeutic approach for Hemophilia B caused by exon-skipping mutations
Pinotti Mirko; FRANCO PAGANI     details >>

Anno: 2014

Residual factor IX expression in Hemophilia B patients with nonsense mutations: a determinant of inhibitory development?
Mirko Pinotti     details >>

Anno: 2014

PIATTAFORMA PER RICERCA E SVILUPPO DI PROFARMACI BIOTECNOLOGICI INNOVATIVI PER LA CURA DI MALATTIE GENETICHE RARE
F. Bernardi; M. Pinotti     details >>

Anno: 2011

RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations. PROGETTO TELETHON TRIENNALE
M. Pinotti     details >>

Anno: 2009

POST-TRANSCRIPTIONAL AND TRANSLATIONAL MECHANISMS UNDERLYING THE REGULATION OF GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL CONDITIONS- progetto PRIN
M. Pinotti     details >>

Anno: 2008

Modulation of activators and inhibitors of coagulation by Reactive Oxygen Species (ROS) Progetto PRIN - Coordinatore Unità B
M. Pinotti     details >>

Anno: 2004